BSE Live
Sep 08, 16:01Prev. Close
844.10
Open Price
828.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 08, 15:54Prev. Close
844.70
Open Price
838.90
Bid Price (Qty.)
844.00 (38)
Offer Price (Qty.)
844.80 (23)
Balance Sheet of Shilpa Medicare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 9.78 | 8.68 | 8.68 | 8.68 | 8.15 | |
Total Share Capital | 9.78 | 8.68 | 8.68 | 8.68 | 8.15 | |
Reserves and Surplus | 2,690.81 | 2,134.04 | 2,108.90 | 2,056.99 | 1,629.68 | |
Total Reserves and Surplus | 2,690.81 | 2,134.04 | 2,108.90 | 2,056.99 | 1,629.68 | |
Total Shareholders Funds | 2,700.59 | 2,142.72 | 2,117.58 | 2,065.67 | 1,637.83 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 24.47 | 16.25 | 122.80 | 120.28 | 324.52 | |
Deferred Tax Liabilities [Net] | 42.43 | 24.87 | 26.18 | 75.04 | 56.84 | |
Other Long Term Liabilities | 8.31 | 5.01 | 8.56 | 9.00 | 10.46 | |
Long Term Provisions | 3.98 | 3.40 | 0.83 | 5.83 | 13.76 | |
Total Non-Current Liabilities | 79.18 | 49.53 | 158.37 | 210.15 | 405.58 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 82.43 | 126.30 | 164.61 | 73.75 | 328.91 | |
Trade Payables | 22.19 | 52.69 | 31.92 | 23.90 | 56.91 | |
Other Current Liabilities | 67.06 | 33.69 | 35.30 | 516.00 | 76.99 | |
Short Term Provisions | 55.20 | 13.66 | 9.57 | 6.65 | 11.17 | |
Total Current Liabilities | 226.89 | 226.34 | 241.41 | 620.30 | 473.98 | |
Total Capital And Liabilities | 3,006.66 | 2,418.58 | 2,517.36 | 2,896.12 | 2,517.39 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 682.16 | 504.11 | 516.98 | 548.30 | 624.29 | |
Intangible Assets | 129.47 | 82.22 | 91.95 | 17.48 | 16.61 | |
Capital Work-In-Progress | 39.46 | 9.92 | 41.84 | 52.57 | 297.19 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 851.09 | 814.57 | 835.36 | 858.89 | 1,123.24 | |
Non-Current Investments | 1,279.50 | 246.45 | 243.92 | 237.50 | 219.32 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 388.70 | 946.89 | 785.63 | 577.97 | 357.94 | |
Other Non-Current Assets | 10.08 | 33.75 | 17.50 | 17.85 | 37.00 | |
Total Non-Current Assets | 2,529.38 | 2,041.66 | 1,882.41 | 1,692.22 | 1,737.50 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 148.58 | 111.92 | 94.50 | 101.77 | 299.08 | |
Trade Receivables | 190.52 | 143.82 | 111.90 | 102.73 | 218.27 | |
Cash And Cash Equivalents | 4.42 | 3.13 | 4.83 | 15.83 | 115.27 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | |
OtherCurrentAssets | 133.76 | 118.06 | 423.71 | 983.56 | 147.27 | |
Total Current Assets | 477.29 | 376.93 | 634.95 | 1,203.90 | 779.90 | |
Total Assets | 3,006.66 | 2,418.58 | 2,517.36 | 2,896.12 | 2,517.39 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 655.24 | 510.05 | 374.38 | 207.79 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 8.52 | 49.40 | 217.59 | 223.09 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 37.95 | 90.47 | 63.82 | 109.08 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | 1.61 | 1.21 | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | 282.38 | 277.03 | 651.36 | 507.79 | |
Other Earnings | -- | 8.85 | 7.10 | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | 3.78 | 3.78 | 3.78 | 3.78 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | 246.45 | 243.92 | 237.50 | 219.32 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
16.07.2025
Shilpa Medicare shares surge 4 percent as key unit gets a VAI classification from US drug regulator
07.07.2025
27.05.2025
Shilpa Standalone March 2025 Net Sales at Rs 126.15 crore, up 44.26% Y-o-Y
27.05.2025
27.05.2025
Shilpa Standalone March 2025 Net Sales at Rs 126.15 crore, up 44.26% Y-o-Y
20.02.2025
Shilpa Consolidated December 2024 Net Sales at Rs 319.32 crore, up 11.46% Y-o-Y
14.02.2025
Shilpa Standalone December 2024 Net Sales at Rs 125.39 crore, up 95.98% Y-o-Y
28.11.2024
Shilpa Consolidated September 2024 Net Sales at Rs 343.80 crore, up 9.85% Y-o-Y